These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8224641

  • 21. The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.
    Chakder S, Rattan S.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):392-9. PubMed ID: 8392560
    [Abstract] [Full Text] [Related]

  • 22. Characterization of vasoactive intestinal peptide receptors in human liver.
    Rodríguez-Henche N, Rodríguez-Pena MS, Guijarro LG, Prieto JC.
    Biochim Biophys Acta; 1994 Mar 31; 1221(2):193-8. PubMed ID: 8148398
    [Abstract] [Full Text] [Related]

  • 23. Characterization of functional receptors for vasoactive intestinal peptide in bovine cerebral arteries.
    Suzuki Y, McMaster D, Huang M, Lederis K, Rorstad OP.
    J Neurochem; 1985 Sep 31; 45(3):890-9. PubMed ID: 2993516
    [Abstract] [Full Text] [Related]

  • 24. Effects of GTP analogs and dithiothreitol on the binding properties of the vascular vasoactive intestinal peptide receptor.
    Huang M, Rorstad OP.
    Can J Physiol Pharmacol; 1989 Aug 31; 67(8):851-6. PubMed ID: 2557141
    [Abstract] [Full Text] [Related]

  • 25. Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking.
    McArthur KE, Wood CL, O'Dorisio MS, Zhou ZC, Gardner JD, Jensen RT.
    Am J Physiol; 1987 Mar 31; 252(3 Pt 1):G404-12. PubMed ID: 2435170
    [Abstract] [Full Text] [Related]

  • 26. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
    Guijarro LG, Rodriguez-Henche N, García-López E, Noguerales F, Dapena MA, Juarranz MG, Prieto JC.
    J Clin Endocrinol Metab; 1995 Aug 31; 80(8):2451-7. PubMed ID: 7629241
    [Abstract] [Full Text] [Related]

  • 27. Galanin receptor in plasma membrane of canine small intestinal circular muscle.
    Chen CK, McDonald TJ, Daniel EE.
    Am J Physiol; 1994 Jan 31; 266(1 Pt 1):G113-7. PubMed ID: 7508197
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Multiplicity of receptors for vasoactive intestinal polypeptide (VIP): differential effects of apamin on binding in brain, uterus and liver.
    Fahrenkrug J, Gammeltoft S, Staun-Olsen P, Ottesen B, Sjöquist A.
    Peptides; 1983 Jan 31; 4(2):133-6. PubMed ID: 6312430
    [Abstract] [Full Text] [Related]

  • 31. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site.
    Luis J, Martin JM, el Battari A, Reynier M, Marvaldi J, Pichon J.
    Eur J Biochem; 1989 Mar 15; 180(2):429-33. PubMed ID: 2538330
    [Abstract] [Full Text] [Related]

  • 32. Identification of vasoactive intestinal polypeptide (VIP) binding protein in bovine pineal gland.
    Samejima M, Stallwood D, Paul S, Ebadi M.
    Neurochem Int; 1993 Jun 15; 22(6):583-8. PubMed ID: 8513286
    [Abstract] [Full Text] [Related]

  • 33. Vasoactive intestinal peptide (VIP) receptors in the canine gastrointestinal tract.
    Zimmerman RP, Gates TS, Mantyh CR, Vigna SR, Boehmer CG, Mantyh PW.
    Peptides; 1988 Jun 15; 9(6):1241-53. PubMed ID: 2854625
    [Abstract] [Full Text] [Related]

  • 34. Characterization and localization of vasoactive intestinal peptide receptors in the rat lung.
    Leroux P, Vaudry H, Fournier A, St-Pierre S, Pelletier G.
    Endocrinology; 1984 May 15; 114(5):1506-12. PubMed ID: 6325122
    [Abstract] [Full Text] [Related]

  • 35. Vasoactive intestinal polypeptide: specific binding to rat brain membranes.
    Taylor DP, Pert CB.
    Proc Natl Acad Sci U S A; 1979 Feb 15; 76(2):660-4. PubMed ID: 218214
    [Abstract] [Full Text] [Related]

  • 36. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C, Bawab W, de Cremoux P, Calvo F.
    Cancer Res; 1988 Sep 15; 48(18):5079-83. PubMed ID: 2842044
    [Abstract] [Full Text] [Related]

  • 37. Neuropeptide release from the isolated, perfused, lower esophageal sphincter region of the rabbit and the effect of vasoactive intestinal peptide on the sphincter.
    Yamashita Y, Kako N, Homma K, Hirai T, Hinder RA, DeMeester TR, Toge T, Adrian TE.
    Surgery; 1992 Aug 15; 112(2):227-33; discussion 233-4. PubMed ID: 1641762
    [Abstract] [Full Text] [Related]

  • 38. The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes.
    Pineau N, Lelievre V, Goursaud S, Hilairet S, Waschek JA, Janet T, Muller JM.
    Neuropeptides; 2001 Apr 15; 35(2):117-26. PubMed ID: 11384207
    [Abstract] [Full Text] [Related]

  • 39. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
    Gottschall PE, Tatsuno I, Miyata A, Arimura A.
    Endocrinology; 1990 Jul 15; 127(1):272-7. PubMed ID: 2361473
    [Abstract] [Full Text] [Related]

  • 40. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
    Salomon R, Couvineau A, Rouyer-Fessard C, Voisin T, Lavallée D, Blais A, Darmoul D, Laburthe M.
    Am J Physiol; 1993 Feb 15; 264(2 Pt 1):E294-300. PubMed ID: 8383439
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.